Here is the podcast of my presentation.


http://cheryl-kraemer.podomatic.com/entry/2014-12-21T18_22_37-08_00

Cheryl Kraemer/ Module 7

Jain, K. (2011). The role of nanobiotechnology in the development of personalized medicine.  Medical Principles and Practice (20. 1-3.

Why was this article, blog, post, or multimedia chosen?

     I chose this article because its title contained two of this week’s topics:  nanotechnology and personalized medicine.

What makes it interesting, appropriate, or reputable?

     The article is interesting because it discusses the intertwining of nanotechnology and personalized medicine.  It discusses how personalized medicine can integrate nanotechnology into medicine to increase understanding of the pathomechanism of diseases and integration with therapeutics.  Nanobiotechnology contributes to personalized medicine with refinement of diagnostic studies and therapeutics, including the interactions among them.

Is it an opinion? Case study? Research study? Product review?

     It is an opinion. 

What was the need, problem, issue or trend addressed in the article, blog, post, or multimedia?

     The issue is the continued quest for better diagnostics and treatments with fewer side effects.  

What was the solution for which technology had an answer?

     Biomarkers which are indicators of some diseases and guide treatments have been discovered by nanobiotechnology.  Nanobiotechnology has also provided refinements in drug discovery and formulations for targeted drug delivery.  The multifunctionality of nanotechnology makes it useful in several imaging modalities. 

What implications might this have in healthcare delivery?

     The implications of nanobiotechnology in personalized medicine include the diagnosis and treatment of presymptomatic diseases.  Nanobiosensors and nanobiochips are used to improve drug discovery leading to personalization at an earlier stage.  Additionally, nanoparticles can deliver contrast medium for diagnostic purposes and drug therapies simultaneously.   Nanoimmunochemotherapy is an example of a combination nanoparticle used in treating cancer.

What did you learn from it that might have application for your practice?

     I learned that nanotechnology and personalized medicine are interrelated.  Technology has the ability to fine tune diagnostics and therapeutics to provide the biggest benefit with the least amount of harm using nanotechnology combined with personalized medicine.

Cheryl Kraemer  Module 6

Glaser, J., & Overhage, J. M. (2013). The role of healthcare IT: becoming a learning organization. Hfm (Healthcare Financial Management), 67(2), 57-63.

Why was this article, blog, post, or multimedia chosen?

     This article was chosen because it discusses the Institute of Medicine’s 2012 Report “Best Care at Lower Cost: The Path to Continuously Learning Health Care in America.  The report provides recommendations “for building a health care delivery system that learns from and evolves with every patient interaction”. (p57)

What makes it interesting, appropriate, or reputable?

       It is reputable because the recommendations are from the Institute of Medicine, a non-profit, non-governmental agency whose goal is to improve the nation’s health.  IOM suggests that “Americans should be served by a healthcare system that consistently delivers reliable performance and constantly improves, systematically and seamlessly, with each experience and transition” (p.57)    

Is it an opinion? Case study? Research study? Product review?

     It is an opinion or interpretation of the Institute of Medicine’s 2012 report.  

What was the need, problem, issue or trend addressed in the article, blog, post, or multimedia?

     The need identified in the article is the failure of the American healthcare system to provide reliable care and best outcomes while reducing unnecessary care, excessive administrative costs, and missed prevention opportunities.

What was the solution for which technology had an answer?

     -Patient data captured in EHRs,imaging and molecular medicine data

     -Real time analytics and novel decision aids

     -Ease-of-use advancements and effective data capture methods

     -Extended reach of EHRs in gathering data from other processes and sources

What implications might this have in healthcare delivery?

     The implications in healthcare delivery are improved patient care as a result of decreased waste, streamlined care delivery and patient-centered care.  According to the article, a learning organization is described as somewhere people can continue to pursue the results they desire, creative thinking is nurtured and people are continually learning.  Continuous knowledge development is the basis for a learning organization in healthcare.   Business intelligence will be used to determine variations in practice, compare outcomes, realize new revenue opportunities, and reduce costs.  An example of real-time analytics mentioned assessment of costs and quality of alternative care settings.

What did you learn from it that might have application for your practice?

     One question that the article poses in relation to knowledge management is how an organization manages the processes of updating and retiring decision guidance.   This is something that in my organization we currently struggle with, particularly because we have decision support tied to some physician orders sets and there are some order sets that have not been reviewed in several years.